226 related articles for article (PubMed ID: 15380780)
1. Requirements for Th1-dependent immunity against infection with Leishmania major.
von Stebut E; Udey MC
Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
[TBL] [Abstract][Full Text] [Related]
2. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
3. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
Matos I; Mizenina O; Lubkin A; Steinman RM; Idoyaga J
PLoS One; 2013; 8(6):e67453. PubMed ID: 23840706
[TBL] [Abstract][Full Text] [Related]
4. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.
Ramírez-Pineda JR; Fröhlich A; Berberich C; Moll H
J Immunol; 2004 May; 172(10):6281-9. PubMed ID: 15128817
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice.
Remer KA; Apetrei C; Schwarz T; Linden C; Moll H
Eur J Immunol; 2007 Sep; 37(9):2463-73. PubMed ID: 17705130
[TBL] [Abstract][Full Text] [Related]
7. Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection.
Misslitz AC; Bonhagen K; Harbecke D; Lippuner C; Kamradt T; Aebischer T
Eur J Immunol; 2004 Mar; 34(3):715-725. PubMed ID: 14991601
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major.
Remer KA; Roeger B; Hambrecht C; Moll H
Immunology; 2010 Dec; 131(4):570-82. PubMed ID: 20673238
[TBL] [Abstract][Full Text] [Related]
9. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
Johnson LM; Scott P
J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
[TBL] [Abstract][Full Text] [Related]
10. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
11. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
12. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
[TBL] [Abstract][Full Text] [Related]
13. A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis.
Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
J Invest Dermatol; 2011 Aug; 131(8):1650-9. PubMed ID: 21525884
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens.
Berberich C; Ramírez-Pineda JR; Hambrecht C; Alber G; Skeiky YA; Moll H
J Immunol; 2003 Mar; 170(6):3171-9. PubMed ID: 12626575
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice.
Von Stebut E; Ehrchen JM; Belkaid Y; Kostka SL; Molle K; Knop J; Sunderkotter C; Udey MC
J Exp Med; 2003 Jul; 198(2):191-9. PubMed ID: 12860932
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
17. IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice.
Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
Exp Dermatol; 2011 Jan; 20(1):76-8. PubMed ID: 20955202
[TBL] [Abstract][Full Text] [Related]
18. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
Weiss R; Scheiblhofer S; Thalhamer J; Bickert T; Richardt U; Fleischer B; Ritter U
Vaccine; 2007 Jan; 25(1):25-33. PubMed ID: 17064826
[TBL] [Abstract][Full Text] [Related]
19. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
20. Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major.
Zahn S; Wirtz S; Birkenbach M; Blumberg RS; Neurath MF; von Stebut E
Eur J Immunol; 2005 Apr; 35(4):1106-12. PubMed ID: 15756639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
